These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 10677093

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
    Karagas MR, Greenberg ER, Mott LA, Baron JA, Ernster VL.
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
    [Abstract] [Full Text] [Related]

  • 3. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.
    Karagas MR, McDonald JA, Greenberg ER, Stukel TA, Weiss JE, Baron JA, Stevens MM.
    J Natl Cancer Inst; 1996 Dec 18; 88(24):1848-53. PubMed ID: 8961975
    [Abstract] [Full Text] [Related]

  • 4. Sun protection for preventing basal cell and squamous cell skin cancers.
    Sánchez G, Nova J, Rodriguez-Hernandez AE, Medina RD, Solorzano-Restrepo C, Gonzalez J, Olmos M, Godfrey K, Arevalo-Rodriguez I.
    Cochrane Database Syst Rev; 2016 Jul 25; 7(7):CD011161. PubMed ID: 27455163
    [Abstract] [Full Text] [Related]

  • 5. Effect of NSAIDs on the recurrence of nonmelanoma skin cancer.
    Grau MV, Baron JA, Langholz B, Karagas M, Greenberg ER, Stukel TA, Mandel JS.
    Int J Cancer; 2006 Aug 01; 119(3):682-6. PubMed ID: 16496410
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW, Weinstock MA, Feldman SR, Coldiron BM.
    JAMA Dermatol; 2015 Oct 01; 151(10):1081-6. PubMed ID: 25928283
    [Abstract] [Full Text] [Related]

  • 8. A randomized trial of beta carotene and age-related cataract in US physicians.
    Christen WG, Manson JE, Glynn RJ, Gaziano JM, Sperduto RD, Buring JE, Hennekens CH.
    Arch Ophthalmol; 2003 Mar 01; 121(3):372-8. PubMed ID: 12617708
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.
    Marcil I, Stern RS.
    Arch Dermatol; 2000 Dec 01; 136(12):1524-30. PubMed ID: 11115165
    [Abstract] [Full Text] [Related]

  • 11. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
    Moon TE, Levine N, Cartmel B, Bangert JL, Rodney S, Dong Q, Peng YM, Alberts DS.
    Cancer Epidemiol Biomarkers Prev; 1997 Nov 01; 6(11):949-56. PubMed ID: 9367069
    [Abstract] [Full Text] [Related]

  • 12. Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial.
    Liu S, Ajani U, Chae C, Hennekens C, Buring JE, Manson JE.
    JAMA; 1999 Sep 15; 282(11):1073-5. PubMed ID: 10493207
    [Abstract] [Full Text] [Related]

  • 13. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study.
    Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH.
    J Natl Cancer Inst; 1999 Dec 15; 91(24):2102-6. PubMed ID: 10601381
    [Abstract] [Full Text] [Related]

  • 14. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.
    Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL, Park HK, Sanders BB, Smith CL, Taylor JR.
    JAMA; 1996 Dec 25; 276(24):1957-63. PubMed ID: 8971064
    [Abstract] [Full Text] [Related]

  • 15. Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia.
    Pandeya N, Olsen CM, Thompson BS, Dusingize JC, Neale RE, Green AC, Whiteman DC, QSkin Study.
    Br J Dermatol; 2019 Oct 25; 181(4):749-760. PubMed ID: 30920641
    [Abstract] [Full Text] [Related]

  • 16. Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial.
    Clouser MC, Roe DJ, Foote JA, Harris RB.
    Pharmacoepidemiol Drug Saf; 2009 Apr 25; 18(4):276-83. PubMed ID: 19226541
    [Abstract] [Full Text] [Related]

  • 17. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
    Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA, VATTC Trial.
    J Natl Cancer Inst; 2008 Sep 03; 100(17):1223-32. PubMed ID: 18728281
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention.
    Deady S, Sharp L, Comber H.
    Br J Dermatol; 2014 Aug 03; 171(2):324-31. PubMed ID: 24666396
    [Abstract] [Full Text] [Related]

  • 20. A phase III skin cancer chemoprevention study of DFMO: long-term follow-up of skin cancer events and toxicity.
    Kreul SM, Havighurst T, Kim K, Mendonça EA, Wood GS, Snow S, Borich A, Verma A, Bailey HH.
    Cancer Prev Res (Phila); 2012 Dec 03; 5(12):1368-74. PubMed ID: 23060038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.